BioCardia, Inc. (BCDA) Earnings History
Annual and quarterly earnings data from 1995 to 2024
Loading earnings history...
BCDA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BCDA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | -7463.8% | -13794.8% | -13700.0% |
| 2023 | -1519.7% | -2441.1% | -2425.8% |
| 2022 | -553.4% | -880.3% | -880.7% |
| 2021 | 36.9% | -1244.3% | -1243.4% |
| 2020 | 97.2% | -10709.7% | -10347.6% |
Download Data
Export BCDA earnings history in CSV or JSON format
Free sign-in required to download data
BioCardia, Inc. (BCDA) Earnings Overview
As of May 8, 2026, BioCardia, Inc. (BCDA) reported trailing twelve-month net income of -$9M, reflecting +64.6% year-over-year growth. The company earned $-1360.34 per diluted share over the past four quarters, with a net profit margin of -13700.0%.
Looking at the long-term picture, BCDA's historical earnings data spans multiple years. The company achieved its highest annual net income of $10M in fiscal 2011.
BioCardia, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MCRB (-$47M net income, 721.9% margin), ANIK (-$11M net income, -9.6% margin), NVCR (-$173M net income, -20.8% margin), BCDA has room to improve margins relative to the peer group. Compare BCDA vs MCRB →
BCDA Earnings vs Peers
Earnings metrics vs comparable public companies
BCDA Historical Earnings Data (1995–2024)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$8M | +31.3% | -$8M | $-2.90 | -13700.0% | -13794.8% |
| 2023 | -$12M | +2.8% | -$12M | $-8.19 | -2425.8% | -2441.1% |
| 2022 | -$12M | +5.7% | -$12M | $-10.05 | -880.7% | -880.3% |
| 2021 | -$13M | +15.9% | -$13M | $-11.19 | -1243.4% | -1244.3% |
| 2020 | -$15M | -2.0% | -$16M | $-22.20 | -10347.6% | -10709.7% |
| 2019 | -$15M | -5.2% | -$14M | $-39.15 | -2071.7% | -2001.8% |
| 2018 | -$14M | -13.6% | -$14M | $-48.80 | -2237.9% | -2256.3% |
| 2017 | -$12M | -19.4% | -$12M | $-43.50 | -2569.5% | -2589.8% |
| 2016 | -$10M | -3301.9% | -$8M | $-166.33 | -1789.9% | -1320.8% |
| 2015 | $322,000 | +37.6% | $319,000 | $27.86 | 62.3% | 61.7% |
See BCDA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BCDA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BCDA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBCDA — Frequently Asked Questions
Quick answers to the most common questions about buying BCDA stock.
Is BCDA growing earnings?
BCDA EPS is $-1360.34, with earnings growth accelerating to +64.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-9M.
What are BCDA's profit margins?
BioCardia, Inc. net margin is -13700.0%, with operating margin at -13794.8%. Below-average margins reflect competitive or cost pressures.
How consistent are BCDA's earnings?
BCDA earnings data spans 1995-2024. The accelerating earnings trend is +64.6% YoY. Historical data enables comparison across business cycles.